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Mabs H36 (IgG2a) and H37 (IgG3) recognize epitopes in antigenic sites Sb and Ca2, respectively, in the HA1 subunit of
influenza virus A/PR/8/34 (H1N1). Their neutralization was complex. Our aim here was to investigate the mechanism of
neutralization by the IgGs and their Fabs. In MDCK and BHK cells, both IgGs neutralized primarily by inhibiting virus–cell
fusion, although at higher IgG concentrations virus attachment to target cells was also inhibited. In contrast, the Fabs
neutralized entirely by inhibiting virus attachment, although a higher concentration of Fab than IgG was required to bring this
about. Both H36 and H37 exerted a concentration-dependent spectrum of neutralization activity, with virus–cell fusion
inhibition and virus–cell attachment inhibition being the predominant mechanisms at low- and high-antibody concentration,
respectively, and both mechanisms occurring simultaneously at intermediate concentrations. However, it may be that
attachment inhibition was a secondary event, occurring to virus that had already been neutralized through inhibition of its
fusion activity. Neutralization by H36 and H37 Fabs was a simple process. Both inhibited virus attachment but required much
higher (.100-fold) molar concentrations for activity than did IgG. The functional affinities of the IgGs were high (0.4–0.6 nM)
and differences between these and the affinity of their Fabs (H36, nil; H37, 23-fold) were not sufficient to explain the
differences observed in neutralization. Similar neutralization data were obtained in two different cell lines. The dose–
response curve for neutralization by H36 F(ab9)2 resembled that for IgG, although eightfold more F(ab9)2 was required for 50%
neutralization. Overall, neutralization mechanisms of H36 and H37 antibodies were similar, and thus independent of antigenic
site, antibody isotype, and target cell. © 2000 Academic PressKey Words: influenza A virus; neutralization; IgG; Fab; F(ab9)2; affinity; mechanism of neutralization; inhibition of attachment;
inhibition of internalization; inhibition of fusion.INTRODUCTION
Neutralization is an in vitro process in which virus
binds antibody and loses infectivity (Dimmock, 1993). It
correlates strongly, though not exclusively, with protec-
tion from infection in vivo. Exactly how the antibody
brings about neutralization and what functions of the
virion are inhibited during neutralization are poorly un-
derstood. However, it was previously established that
neutralization is complex and multifactorial and, for any
one virus, is governed by factors that include the virus
strain, the epitope, the cell type, and the antibody iso-
type, affinity, and concentration. While it is never possible
to show unequivocally how a virus is neutralized, loss of
infectivity can, with care, be correlated with the loss of
particular viral functions that are known to be essential in
the initial stages of infection. To establish a putative
causal relationship, however, loss of a particular virus
1 Present address: The Edward Jenner Institute for Vaccine Re-
earch, Compton RG20 7NN, UK.
2 To whom correspondence and reprint requests should be ad-
dressed. Fax: 144 1 2476 523593. E-mail: ndimmock@bio.warwick.
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423function must be able to account quantitatively for the
loss of infectivity as represented by the antibody dose–
neutralization curve or kinetics of neutralization.
Although influenza A viruses are important human
pathogens, their natural reservoir is aquatic birds (Web-
ster, 1998). There are 135 subtypes defined by the per-
mutation of the two major surface antigens, the hemag-
glutinin (HA; of which there are 15 antigenic forms) and
the neuraminidase (of which there are 9), and each
subtype contains many different strains. So far only 4
subtypes (H1N1, H2N2, H3N2, and H3N8) have spread in
the human population, but there is serious concern for
human health with viruses crossing the species barrier,
such as the H5N1 in Hong Kong that recently caused
38% mortality (Centers for Disease Control and Preven-
tion, 1998). The major neutralization antigen is the HA,
and protection from infection in humans is due largely to
humoral immunity (Ghendon, 1990).
Neutralization of viruses by Fabs is potentially a sim-
pler process than neutralization by IgG, as Fabs can bind
only monovalently to virions. Thus study of Fabs can help
elucidate neutralization mechanisms. Most Fabs have at
least an order of magnitude less neutralization activity on
a molar basis compared with that of their IgG, although
0042-6822/00 $35.00
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424 EDWARDS AND DIMMOCKsome neutralize more efficiently (Kingsford et al., 1991;
tewart et al., 1997). Fabs were classified into five cate-
ories according to their change in affinity and neutral-
zing ability relative to their parent antibody, but only in
ome cases was the difference between IgG and Fab
eutralization explicable in terms of reduced Fab affinity
Schofield et al., 1997b). Almost nothing is known about
ow Fabs neutralize influenza A viruses, and there is
ery little information about the mechanism of Fab neu-
ralization of viruses in general. Neutralization of HIV-1
nfection of the C8166 T-cell line by the human b12 Fab
iffered from that of its IgG1. While neither affected at-
achment of neutralized virus to the target cell sufficiently
o account for neutralization (McInerney et al., 1997;
golini et al., 1997), the IgG inhibited fusion coordinately
ith neutralization, while its Fab neutralized virus without
ffecting its fusion activity (McInerney et al., 1997).
Previous work showed that IgG neutralization of influ-
nza A virus is complex and that loss of infectivity occurs
n a variety of ways, depending on several different
ariables as discussed above. Neutralization did not (1)
nhibit attachment of virus to the target cell (Possee and
immock, 1981; Possee et al., 1982; Dimmock et al.,
1984; Taylor and Dimmock, 1985; Rigg et al., 1989), and
neutralized virus attached via neuraminidase-sensitive
receptors (Outlaw et al., 1990). With other virus strains
and/or antibodies, neutralization was accompanied by
(2) partial inhibition of virus to the target cell (Outlaw and
Dimmock, 1990, 1993; Outlaw et al., 1990. (3) Internaliza-
tion of neutralized virus that attach to cells, however, was
not inhibited (Outlaw et al., 1990; Outlaw and Dimmock,
993). There was also (4) partial inhibition of fusion
ctivity of cell-associated virus (Outlaw and Dimmock,
993), (5) complete inhibition of fusion activity of cell-
ssociated virus (Outlaw and Dimmock, 1993), or (6) no
nhibition of fusion. With the latter, neutralization was
ssociated with inhibition of a postfusion event (Possee
nd Dimmock, 1981; Possee et al., 1982; Dimmock et al.,
1984; Rigg et al., 1989) and was also seen during neu-
ralization by polymeric IgA (Armstrong and Dimmock,
992). A combination of partial inhibition of attachment
nd partial inhibition of fusion (7) could theoretically have
ccounted for neutralization (Outlaw and Dimmock,
993). Aggregation of virus (8) played only a minor role in
educing infectivity and was always restricted to a par-
icular window of antibody concentration (Outlaw and
immock, 1990; Outlaw et al., 1990).
We report here on the mechanism of neutralization of
n H1N1 influenza A virus by an HA1-specific monoclo-
al IgG2a and an IgG3, and their Fabs. In MDCK and
HK cells, both IgGs neutralized primarily by inhibiting
irus–cell fusion, although at higher IgG concentrations
irus attachment to target cells was also inhibited. In
ontrast, the Fabs neutralized entirely by inhibiting virus
ttachment, but a higher concentration of Fab than of IgG
as required to bring this about.
n
FRESULTS
ocation of epitopes of Mabs H36 and H37 on the
iral hemagglutinin
Mab H36 (IgG2a) binds to an epitope in antigenic site
b at the distal tip of the HA1 subunit that equates to site
of the H3 HA, and H37 (IgG3) binds to site Ca2, which
ncompasses a loop on the globular head of HA1 that
quates to site A of the H3 HA (Fig. 1) (Caton et al., 1982;
taudt and Gerhard, 1983). RT-PCR and sequencing of
eutralization escape mutants implied that there were
ingle residue changes in the expected antigenic sites.
ith H36 IgG the majority of escape mutants had
52D3 K, and with H37 IgG the majority had 140K3 D
A. C. Marriott, C. Parry, and N. J. Dimmock, unpublished
ata).
eutralization efficiencies of H36 IgG, F(ab9)2 and
ab, and H37 IgG and Fab
Figure 2a shows that H36 IgG, F(ab9)2, and Fab all
ave .99% neutralization of virus infectivity, but neutral-
zation efficiency decreased in the order IgG . F(ab9)2 .
ab. Curves were fitted by nonlinear regression analysis
nd neutralization efficiencies were calculated. These
howed that 50% neutralization (N50) required 8-fold more
(ab9)2, in molar terms, and 104-fold more Fab (Table 1).
nterestingly this differential decreased with increasing
FIG. 1. Location of the antigenic sites of Mabs H36 and H37 on a
monomer of the HA of PR8 (adapted from Wiley et al. (1981) and Caton
et al. (1982)).eutralization, such that N90 required 2.5-fold more
(ab9)2 and 15-fold more Fab than IgG. Fab neutralization
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425COMPLEX AND SIMPLE NEUTRALIZATIONoccurred over a narrower concentration range than did
IgG neutralization. Neutralization by Mab H37 was es-
sentially similar to that of H36 IgG, except that approxi-
mately 10-fold more H37 IgG was required for N50 than
with H36 IgG and that H37 IgG achieved .99% neutral-
ization over a narrower concentration range than did H36
IgG (Figs. 2a and 2b). H37 Fab was also neutralizing,
though the N50 required approximately 360-fold more
than did the IgG. As H37 IgG is completely degraded by
pepsin, its F(ab9)2 could not be studied. Again H37
howed a differential in the ratio of IgG:Fab required for
50 and N90, although of only 2-fold. Similar data were
obtained when neutralization assays were conducted in
BHK cells (data not shown).
H36 and H37 IgG neutralized more infectivity than
could be accounted for by inhibition of virus
attachment to the target cell
Dose–response curves are shown for neutralization
FIG. 2. Dose–response relationship of the percentage infectivity of
PR8 remaining after incubation with increasing concentrations of Mabs
(a) H36 and (b) H37 for 1 h at 37°C. IgG, (f); F(ab9)2, (); Fab, (). Virus
ontrols gave approximately 40 PFU/plate. Data are from plaque as-
ays in MDCK cells and are the means of three experiments each with
ive replicates. Bars represent the SEM. Curves (R . 0.98) were
enerated by nonlinear regression analysis using Prism Graphpad
oftware.and inhibition of virus attachment to cells for a range of
H36 and H37 IgG and Fab concentrations in MDCK andBHK cells. IgG and Fab data are based on 20 and 12
replicate assays, respectively. Neuraminidase pretreat-
ment of the target cell monolayer reduced the level of
attachment of both nonneutralized and neutralized virus
by .90%, showing that both used NANA receptors and
hat binding to Fc receptors was not involved. In all
ases, attachment of virus decreased with increasing
eutralization, although the correlation between the
urves for H36 IgG was poor (Figs. 3a and 3b), as
etermined by an unpaired t test, showing that they were
significantly different (p 5 0.001 and 0.005, respectively,
here 0.05 is considered significant). The H37 curves
ollowed the same trend and, although the difference
as not so marked, they were still significantly different
p 5 0.027 and 0.047, respectively; Figs. 3c and 3d). At
N50, there was only 5–20% inhibition of attachment, indi-
ating that the majority of virus was neutralized by some
ther mechanism (Table 2). Inhibition of attachment in-
reased, however, relative to neutralization with increas-
ng IgG concentration, so that at N90 inhibition of virus
ttachment accounted for the majority of the observed
eutralization (summarized in Table 2). The comparison
f neutralization and inhibition of attachment is legiti-
ate, as we used the same experimental system, same
ized monolayers, same virus–antibody mix, and same
noculum volume, etc., for both assays.
The H36 and H37 Fab data were in marked contrast to
he data obtained with their IgGs, as the neutralization
nd inhibition of virus–cell attachment curves were vir-
ually superimposable (Figs. 3e–3h) and did not differ
ignificantly by the unpaired t test (values shown in Fig.
). All required $86-fold more Fab than IgG for equiva-
ent neutralization. Thus Fab neutralization and inhibition
f virus attachment appeared to be causally related. H36
ab showed a much steeper dose–response curve than
id H36 IgG (compare Figs. 3a and 3b with 3e and 3f; Fig.
a). All aspects of the ELISA and the plaque assay
TABLE 1
Comparison of the Neutralizing Activities of H36 and H37 IgG and
Their Antibody Fragments in MDCK Cell Monolayers
Antibody
Concentration (nM)
required to give
neutralization of
Antibody fragment:
IgG ratio at
neutralization of
50% 90% 50% 90%
36
IgG 0.5 6.0 NA
F9(ab9)2 4.0 15.0 8:1 2.5:1
Fab 52.0 90.0 104:1 15.0:1
37
IgG 5.0 14.0 NA
Fab 1800.0 2500.0 360:1 178.0:1Note. Plaque assay data from Fig. 2.
c426 EDWARDS AND DIMMOCKFIG. 3. Dose–response relationship between the percentage infectivity and percentage attachment of virus to MDCK (a, c, e, g) and BHK cells (b,
d, f, h) as a function of IgG and Fab concentration. Data are for H36 IgG (a, b), H36 Fab (e, f), H37 IgG (c, d), and H37 Fab (g, h). Infectivity and attachment
were assayed in parallel by ELISA in the same batch of monolayers in 96-well plates, using the same virus–antibody mixtures. Virus and antibody
were incubated together for 1 h at 37°C. , percentage infectivity; f, percentage attachment of virus to cells; *, percentage attachment of virus to
ells pretreated with Clostridium perfringens neuraminidase. Data with IgG are the means of five experiments each with four replicates, and for Fab
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427COMPLEX AND SIMPLE NEUTRALIZATIONneutralization data shown in Figs. 3 and 2 were compa-
rable.
In conclusion, neutralization by H36 and H37 Fabs
appeared to be a simple process, related directly to the
inhibition of virus attachment to the target cell, whereas
IgG neutralization was complex and involved the inhibi-
tion of at least two virus activities. Counterintuitively, H36
IgG neutralized the majority of the virus population at low
concentration by a mechanism other than the inhibition
of virus attachment. Possible reasons that the Fabs re-
quired an 87- to 320-fold higher molar concentration than
IgG for 50% neutralization are discussed below.
H36 and H37 IgG-neutralized virus that attached to
target cells was internalized
The next phase of the study investigated whether
neutralized virus that attached to target cells had the
ability to be internalized by those cells. After it attaches
to the target cell, influenza virus undergoes receptor-
mediated endocytosis. This was verified in our system by
two treatments that reduce receptor-mediated endocyto-
sis. Cells were either chilled at 4°C (Matlin et al., 1981;
ichman et al., 1986) or pretreated with medium made
ypertonic with sucrose (Daukas and Zigmond, 1985;
euser and Anderson, 1989). For example, internaliza-
ion of nonneutralized or H36-neutralized virus into
DCK cells was inhibited by $92% at 4°C and by $81%
by hypertonic medium. Similar data were obtained for
BHK cells and in other experiments (data not shown).
Figures 4a and 4b show data for a full range of IgG
concentrations. It can be seen that, as infectivity de-
creased with increasing concentration of H36 or H37
IgG, internalization of virus by MDCK cells remained at
approximately 100%, and thus was independent of the
amount of neutralization. The data shown represent only
the virus that attached to cells (see Materials and Meth-
T
Summary of Some Parameters of the Neutralization of
Mab Isotype
Antigenic
site Cell type
N50
a (nM)
IgG Fab
H36 G2a Sb (tip) MDCK 0.6 52
BHK 0.2 63
H37 G3 Ca2 (loop) MDCK 5.0 1600
BHK 10.0 1800
a N50, 50% neutralization by ELISA.
three experiments each with four replicates. Virus controls gave readin
generated as described in Fig. 2. The p values showing the significance of th
npaired t test. A value of p , 0.05 is considered significant.ods). Similar data were obtained with BHK cells (not
shown). Thus virus neutralized by H36 or H37 IgG that
was able to attach to cells was also able to undergo
internalization by the target cell.
H36 and H37 IgG neutralized infectivity and inhibited
the fusion of virions to target cells in parallel
Infection of cells at 37°C with R18-labeled virus results
in fluorescence dequenching consistent with fusion of
virus and cell membranes, as reported by others for a
variety of virus systems (Blumenthal et al., 1987; Steg-
mann et al., 1987; Miller and Hutt-Fletcher, 1988; Haddad
and Hutt-Fletcher, 1989; Outlaw and Dimmock, 1993).
The specificity of this result was confirmed by treatments
that inhibit PR8 virus fusion. Cells were either chilled at
4°C (Tsurudome et al., 1992; Pak et al., 1994) or pre-
treated with bafilomycin, a V-ATPase inhibitor that pre-
vents the acidification of endosomal vesicles required for
triggering HA-mediated fusion (Palokangas et al., 1994;
Ochiai et al., 1995). Preincubating MDCK cells at 4°C
inhibited fusion by 91 6 3%, while treatment with bafilo-
mycin inhibited virus fusion by 88 6 5% (other data were
similar but not shown). Figures 5a–5d show the relation-
ship between IgG neutralization and virus fusion activity
in MDCK and BHK cells. Fusion data were calculated
relative to the percentage of virus that attached to cells,
measured in the same system (see Materials and Meth-
ods). Data show that, as infectivity decreased with in-
creasing IgG concentration, the percentage fusion
curves followed very closely, suggesting a causal rela-
tionship. Although the two curves were not perfectly
superimposable, they did not differ significantly by an
unpaired t test (see Fig. 5 for p values). Thus the majority
of virus that was neutralized by H36 and H37 IgG and
attached to target cells resulted from inhibition of virus–
cell fusion.
y the HA1-Specific H36 and H37 IgGs and Their Fabs
ion (%) of
ent at N50
Inhibition (%) of
attachment at N90
Inhibition of
virus
internalization
by IgG
Inhibition of
virus fusion
by IgGFab IgG Fab
42 73 88 No Yes
49 70 85 No Yes
42 65 88 No Yes
48 61 85 No Yes
.2–1.4 OD units. The bar represents the SEM. Curves (R . 0.98) wereABLE 2
PR8 b
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428 EDWARDS AND DIMMOCKH36 F(ab9)2 neutralized more infectivity than could be
ccounted for by inhibition of virus attachment to the
arget cell
Figure 6 shows the relationship between F(ab9)2 neu-
ralization and the inhibition of attachment of virus to
arget cells. Neuraminidase pretreatment reduced the
evel of virus attachment by .85%, showing that most
irus attached via NANA receptors. Like the IgG neutral-
zation shown in Fig. 2a, a progressively greater propor-
ion of virus neutralization could be accounted for by
nhibition of attachment as the concentration of F(ab9)2
increased. For example, inhibition of virus attachment at
N50 was only 2% and at N90, 78%. Thus, although F(ab9)2
has an eightfold lower specific activity than its IgG, they
both appeared to neutralize in a similar manner. Possible
FIG. 4. Analysis of the relationship between the infectivity of PR8 and
he internalization of virus by MDCK cells as a function of H36 (a) and
37 (b) IgG concentration. Virus and antibody were incubated together
or 1 h at 37°C. Infectivity and internalization were assayed by ELISAs
n the same batch of monolayers in 96-well plates, and using the same
irus–antibody mixtures. , percentage infectivity; columns represent
ercentage internalization. All data are the means of three experiments
ach with four replicates. Internalization was calculated as a percentage
f virus that attached to cells, measured in the same system. Virus controls
ave readings of 0.7–1.0 OD units. The bar represents the SEM.reasons for the lower neutralizing activity of F(ab9)2 are
discussed below.
i
1Measurement of functional affinities of IgGs and
affinities of their Fabs
The on- and off-rates for H36 and H37 IgGs and their
Fabs for immobilized whole virus were measured using
surface plasmon resonance, and the functional affinities
and affinities calculated, respectively. The on- and off-
rates of H36 IgG and Fab were very similar and the
equilibrium values were high and identical. H37 Fab had
a 2-fold lower on-rate and a 7-fold higher off-rate than its
IgG, and its equilibrium value was 23-fold lower (Table 3).
However, all equilibrium values were approximately 9
nM or better, which is the high end of the range for
antibodies.
DISCUSSION
Neutralization by IgG
On a molar basis, H36 IgG had an approximately
10-fold higher neutralizing activity than H37 IgG. Neutral-
ization by both Fabs was considerably reduced (by 87- to
320-fold at 50% neutralization [N50]). More surprising was
the 8-fold lower activity of the H36 F(ab9)2. Inhibition of
virus attachment to target cells did not appear to account
for all the neutralization observed. For example, the N50
of H36 and H37 IgGs in MDCK cells and BHK cells was
accompanied by inhibition of virus attachment that
ranged from 5 to 20% (a 10- to 2.5-fold discrepancy; Table
2). This result was highly reproducible in five repeat
experiments and four replicate assays in each (Figs.
3a–3d). Thus, how the majority of virus lost infectivity was
still unexplained. In an attempt to resolve this, we inves-
tigated the next stages of infection, virus internalization
and virus fusion. We found that neutralized virus that
attached to cells was internalized with the same overall
efficiency as nonneutralized virus (Fig. 4), but that fusion
was inhibited in proportion to neutralization by both H36
and H37 IgGs (Fig. 5). We thus concluded that both IgGs
neutralized the majority of virus by inhibiting viral fusion
and that underlying this was a low level of inhibition of
virus attachment. What made this situation complex was
that, as higher concentrations of IgG were applied, at-
tachment inhibition increased compared with fusion in-
hibition and eventually became the major mechanism of
neutralization.
From the above-noted observations and results we
conclude, first, that neutralization mechanisms effected
by H36 and H37 IgGs proceed in much the same way
and are thus unaffected by differences in antibody iso-
type (IgG2a and IgG3), antigenic site (Sb and Ca2), or
epitope. At the N50, H37 IgG was 10-fold less efficient at
eutralizing in molar terms. This was not explained by its
unctional affinity, which was 1.4-fold higher than that of
36 IgG (Table 3), but may have resulted from the prox-
mity of its antigenic site to the receptor-binding site (Fig.
). Thus the H37 epitope appears to give intrinsically less
nce be
429COMPLEX AND SIMPLE NEUTRALIZATIONneutralization per IgG molecule than does the H36
epitope. Indeed, a similar conclusion was reached ear-
lier with a different combination of influenza A virus and
Mab (Schofield et al., 1997a). Second, it is evident that
H36 and H37 IgGs exert two different neutralization
mechanisms, inhibition of fusion and inhibition of attach-
ment, that operate simultaneously. This suggests that
IgG inhibits fusion at a lower density of IgG molecules
per virion than is required for inhibition of attachment or,
from the virus perspective, that fusion requires a higher
number of free HA spikes than does cell attachment.
However, direct quantitation is required to take this ten-
tative conclusion further. Third, the proportion of virus
putatively neutralized by inhibition of attachment rose
with increasing antibody concentration. We speculate
that this occurs because the number of IgG molecules
bound per virion increases and, as a result, interaction of
the virion with cell receptors is more effectively impeded.
It is probably also the case that such virus was already
neutralized through inhibition of its fusion activity, and
FIG. 5. Analysis of the relationship between the percentage infectivit
as a function of antibody concentration. H36 IgG (a, b); H37 IgG (c, d).
antibody were incubated together for 1 h at 37°C. Percentage infectivit
40 PFU/plate), and percentage inhibition of fusion activity (f) was me
control to background fluorescence was $threefold. Data are the mea
a percentage of virus that attached to cells, measured in the same s
described in Fig. 2, and p values showing the significance of the differe
of p , 0.05 is considered significant.that the extra IgG is simply inhibiting the attachment of
already noninfectious virus. Which mechanism should becited as the primary cause of neutralization? The logic is
straightforward. Fusion inhibition is predominant at
lower IgG concentrations, while attachment inhibition is
a secondary event, requiring more IgG molecules per
virion. However, when virus no longer attaches to target
cells, fusion inhibition becomes irrelevant to neutraliza-
tion; thus, there is a spectrum of neutralization activity
which starts with fusion inhibition and ends with attach-
ment inhibition. In between, both mechanisms of neutral-
ization operate simultaneously, and the proportion of
infectivity that each neutralizes depends on the concen-
tration of IgG applied.
H36 and H37 are a further addition to a group of
HA1-specific antibodies that inhibit influenza A virus-
mediated fusion (Kida et al., 1985; Outlaw and Dimmock,
1993). The Kida antibodies inhibited two different low-
pH-induced conformational changes in soluble HA, as
shown by electron spin resonance, but no quantitative
link with neutralization or virus-directed fusion was es-
tablished (Yoden et al., 1986). Thus it is not clear how any
8 and the percentage fusion of virus to MDCK (a,c) and BHK (b,d) cells
ets of data were obtained using 3-cm-diameter monolayers. Virus and
as determined by plaque reduction (virus controls gave approximately
by fluorescence dequenching of R18-labeled virus. The ratio of virus
ree experiments each with three replicates. Fusion was calculated as
The bar represents the SEM. Curves (R . 0.98) were generated as
tween the two curves were calculated using an unpaired t test. A valuey of PR
Both s
y () w
asured
ns of th
ystem.of the antibodies are able to inhibit the fusion process.
The main requirement for HA1 in the fusion process is
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430 EDWARDS AND DIMMOCKthat it avoids impeding the low-pH-activated HA2 from
making contact with the cell membrane (Hernandez et
al., 1996). The interpretation of how H36 and H37 act is
made more difficult as they recognize different antigenic
sites on HA1 (H36: site Sb (B); H37: site Sa (A); Fig. 1).
Thus inhibition of fusion is not site-specific. We offer two
possible explanations. In the first, IgG interferes steri-
cally with the fusion process, possibly by keeping the
viral and cell membranes apart. In the second, IgGs
inhibit fusion by preventing the three HA1 monomers
from moving out of the way of the low-pH-activated HA2
as it jackknifes toward the cell membrane (Bullough et
al., 1994). It seems unlikely that this is achieved by IgG’s
cross-linking two monomers within an HA trimer, as this
is not observed by electron microscopy (Wrigley et al.,
1977, 1983), but could be achieved by cross-linking two
adjacent HA trimers. However, all HA1 neutralization
epitopes are conformational and many are discontinu-
ous, so inhibition of fusion might be equally achieved by
intraepitope cross-linking under the antibody footprint.
Neutralization by Fab
It is striking that the dose–response curves for inhibi-
tion of attachment and neutralization caused by both H36
and H37 Fabs were essentially identical, although a
higher concentration of H37 Fab was needed (Figs. 3e–
3h; Table 2); a causal relationship is thus strongly sug-
FIG. 6. Analysis of the relationship between infectivity and attach-
ent of PR8 to MDCK target cells as a function of the concentration of
36 F(ab9)2. Infectivity and attachment were assayed by ELISA in
arallel in the same batch of monolayers in 96-well plates, using the
ame virus–antibody mixtures. Virus and antibody were incubated
ogether for 1 h at 37°C. , percentage infectivity; f, percentage
ttachment of virus to cells; *, percentage attachment of virus to cells
retreated with Clostridium perfringens neuraminidase. Data are the
eans of three experiments each with three replicates. Virus controls
ave readings of 1.2–1.4 OD units. The bar represents the SEM. Curves
R . 0.99) were generated as described in Fig. 2, and the p value
howing the significance of the difference between the two curves (,
) was calculated from an unpaired t test. A value of P , 0.05 is
onsidered significant.gested. At first sight this seems counterintuitive, as a Fab
(approximately 50,000 Mr) is threefold smaller than IgGapproximately 150,000 Mr) and would appear to be less
able to sterically interfere with the binding of virus to cell
receptors. However, the specific neutralization activities
of H36 and H37 Fabs are two orders of magnitude lower
than those of their respective IgGs, and it is possible that
this arises because inhibition of attachment by Fab is the
neutralization mechanism and that this requires a large
number of Fab molecules bound per virion. The answer
does not appear to lie with affinity for H36 Fab and IgG,
as they have the same high value (0.56 nM), and, al-
though the affinity of H37 Fab was 23-fold lower than that
of its IgG, it was still high (9 nM) and would not account
for the observed loss of infectivity. Thus the loss in
affinity does not explain the observed loss of Fab neu-
tralization activity. Rather, it would appear that H36 and
H37 Fabs have lost much of the fusion-inhibition ability.
However, if Fabs had simply lost fusion-inhibiting activity,
one would expect the attachment inhibition curves of Fab
and IgG to overlap. However, comparison of Figs. 3a–3d
and 3e–3h shows this is not the case. Specifically, 1027.5
M H36 IgG gave .90% neutralization, but at the same
concentration, Fab neutralization was only just com-
mencing. Moreover, in other experiments we showed
that both H36 and H37 Fabs have the ability to inhibit
postattachment stages of the virus–cell interaction (data
not shown). They were able to neutralize virus already
attached to cells, inhibit fluorescence dequenching
when target cells were infected with R18-labeled virus,
and inhibit the hemolysis of red blood cell–virus com-
plexes (data not shown). Fabs therefore have not totally
lost fusion-inhibiting activity, but carry this out less effi-
ciently than IgG. Thus it appears that neutralization in
general and fusion-inhibition in particular are more effi-
ciently exerted by IgG than Fab because IgGs either bind
bivalently or have a greater mass, or both. In summary,
Fabs were less efficient than IgG at inhibiting virus at-
tachment and were even poorer at inhibiting virus-medi-
ated fusion; it is not yet clear why this is so.
No other data on the mechanism of neutralization of
influenza A virus by Fabs are available. Early work
TABLE 3
Functional Affinities of H36 and H37 IgGs and Affinities of
heir Fabs for Virus Particles Determined by Surface Plasmon
esonance
Antibody
On-rate constant
(M21 s21)
Off-rate
constant (s21)
Equilibrium
dissociation
constant (nM)
H36
IgG 5.88 3 105 3.24 3 1024 0.56
Fab 7.38 3 105 3.75 3 1024 0.56
H37
IgG 4.25 3 105 1.59 3 1024 0.39
Fab 2.48 3 105 2.22 3 1023 9.0Note. Values are the means of four different antibody concentrations.
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431COMPLEX AND SIMPLE NEUTRALIZATIONshowed that Fabs made from a polyclonal neutralizing
IgG were neutralizing, but underwent the dilution disso-
ciation that is normally indicative of a low-affinity asso-
ciation (Lafferty, 1963). Later it was shown that four Fabs
to an H7N7 strain lost 31- to .100-fold neutralizing ac-
tivity compared to their IgGs (Kida et al., 1985). The
echanism of neutralization of another virus, HIV-1 in-
ection of the C8166 T-cell line by the human b12 Fab,
iffered from that of its IgG1 (McInerney et al., 1997).
either inhibited attachment of neutralized HIV-1 to the
arget cell significantly, but b12 IgG inhibited fusion co-
rdinately with neutralization, while its Fab neutralized
ithout affecting fusion and presumably inhibited a post-
usion entry event. Another study found that both b12 IgG
nd Fab had some inhibitory effect on attachment of
IV-1 to the target cell, but the dose–response relation-
hip for attachment inhibition was disproportionately
ess than that for the observed neutralization, demon-
trating that there was not a direct causal relationship
Ugolini et al., 1997).
Schofield et al. (1997b) classified Fabs into five cate-
ories according to their affinity and neutralizing ability.
he H36 and possibly H37 Fabs described here clearly
all into their Category (iii), in which reduction in neutral-
zing activity exceeded loss of affinity by over 10-fold.
his category also includes Fabs specific for mouse
epatitis virus (Lamarre and Talbot, 1995) and an influ-
nza A H7N1 virus (Schofield et al., 1997b).
eutralization by F(ab9)2
The specific neutralization activity of H36 F(ab9)2 was
reduced eightfold compared with that of its IgG, slightly
greater than that found with F(ab9)2 molecules specific to
ther viruses (Lamarre and Talbot, 1995; Schofield et al.,
997b). This is unexpected, as a F(ab9)2 is identical to
IgG in valency and epitope binding site and differs only
in the loss of the Fc region. This finding therefore adds
weight to the above-noted suggestion that a higher mass
of the neutralizing ligand makes for more-efficient neu-
tralization. However, apart from requiring a greater con-
centration to effect neutralization, the relationship be-
tween neutralization and inhibition of virus attachment of
F(ab9)2 was similar to that of IgG described above. That
s, there is insufficient inhibition of attachment at low
(ab9)2 concentrations to explain the observed neutral-
ization.
MATERIALS AND METHODS
Virus
Influenza virus A/Puerto Rico/8/34 (H1N1; PR8) was
grown in the allantoic cavity of 10-day-old embryonated
chicken eggs (Poynden Egg Farm, Goss Oaks, UK) for
48 h at 33°C. Virus was purified by differential centrifu-
gation and then by banding successively on a 10–45%
h(w/v) sucrose gradient at 60,000 g for 90 min and a
20–70% (w/v) sucrose equilibrium gradient at 60,000 g for
6 h. Virus was stored at 270°C.
ells
Madin–Darby canine kidney (MDCK) cells (kindly pro-
ided by Dr. Wendy Barclay) were maintained in DMEM
GibcoBRL Life Technologies, Paisley, UK), 0.02 mM glu-
amine (Gibco), 5% v/v heat-inactivated fetal calf serum
HIFCS; Gibco), and 50 mg/ml gentamicin (Gibco). BHK
ells (ECACC, Porton Down, UK) were cultured in the
ame way but in GMEM (Gibco), 0.02 mM glutamine, 10%
IFCS, and 50 mg/ml gentamicin. Mouse hybridoma cell
ines were grown in RPMI 1640 (Gibco), 10% HIFCS, 2
M glutamine, and 50 mg/ml gentamicin.
Antibodies
The PR8 HA1-specific Mabs H36-4.5-2 (antigenic
site Sb, IgG2a) and H37-45-5R3 (site Ca2, IgG3) were
generously donated by Dr. Walter Gerhard (Caton et
al., 1982; Staudt and Gerhard, 1983). Another HA1-
specific Mab H37-66-1 (site Sb, IgA) and an NP-spe-
cific Mab HB-67 (IgG1) were kindly supplied by Dr.
Gerhard and Dr. Robert G. Webster, respectively. Mabs
were purified by affinity chromatography on a protein
A–Sepharose column (Sigma, Poole, UK) under low-
salt conditions. IgG was eluted with 100 mM glycine
(pH 3) and fractions were neutralized with 1 M Tris–
HCl (pH 8). Peak fractions were concentrated with an
Amicon 8010 pressure concentrator (Amicon, Stone-
house, UK) with a 10,000 M r cutoff filter, dialyzed
gainst PBS, and quantitated by UV absorption (1
D 5 1.35 mg/ml) (Harlow and Lane, 1988).
Production of Fabs by digestion of IgG with papain
IgG2a (1 mg) was mixed with 6.2 ml freshly made 0.01
cysteine (Sigma), 20 ml EDTA, and 1 U agarose-immo-
ilized papain (Sigma) and adjusted to pH 5.5 with 200
M sodium acetate in a final volume of 1 ml. This was
haken for 3 h at 37°C. IgG3 was treated similarly except
ith 1 M cysteine. The reaction was stopped by pelleting
he papain, making the digest 5.5 mM with respect to
odoacetamide (Sigma), and raising the pH with 1 M
ris–HCl (pH 8). The digest was passaged repeatedly
hrough protein A–Sepharose to remove undigested IgG
nd Fc fragments. Fabs were then dialyzed, concen-
rated, and quantitated spectrophotometrically (1 OD 5
.5 mg/ml) (Hudson and Hay, 1989). The Fab preparation
as then analyzed by nonreducing PAGE and stained
ith colloidal Coomassie brilliant blue (Sigma) (Fig. 7). It
ad the expected Mr of approximately 50,000 and was
free of detectable IgG (#50 ng/ml).
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epsin
H36 IgG2a (0.5 mg) was digested with 500 U immobi-
ized pepsin (Sigma) at pH 3.5 for 8 h at 37°C. The
eaction was stopped by pelleting the pepsin and raising
he pH with 3 M Tris–HCl (pH 8). Undigested IgG was
emoved by passage through protein A–Sepharose.
(ab9)2 was then dialyzed and concentrated, and its con-
entration was determined spectrophotometrically. By
onreducing SDS–PAGE, the F(ab9)2 had the expected Mr
of approximately 100,000 and was free of detectable IgG
(#50 ng/ml; Fig. 7). H37 IgG3 was degraded by pepsin
and yielded no F(ab9)2.
Hemagglutination assay
Virus was double diluted in PBS in 96-well round-
bottom plates (Greiner, Stonehouse, UK) and detected by
agglutination of 0.13% chicken red blood cells (CRBC;
Serotech, Kidlington, UK). Agglutination of 50% (1 HAU)
was estimated by interpolation between complete agglu-
tination and no agglutination and the titer expressed as
the reciprocal of the dilution in HAU/ml.
SDS–PAGE of proteins
SDS–PAGE was carried out on 8, 10, or 12% polyacryl-
amide gels with 10 mg protein. Samples were boiled for
3 min in nonreducing loading buffer. After electrophore-
sis, gels were fixed with 40% methanol, 10% acetic acid,
and stained with colloidal Coomassie brilliant blue. IgG
was detected down to 50 ng/ml.
Plaque assay of virus infectivity
MDCK monolayers were grown overnight on six-well
plates (Falcon; Farenheit Lab Supplies, Milton Keynes,
UK) followed by rinsing to remove serum, after which
virus (100 ml) was added and incubated for 45 min at
20°C. Monolayers were then overlaid with 0.9% agar
FIG. 7. Analysis of H36 antibody fragments by nondenaturing SDS–
AGE. Fab (10 mg) was analyzed on an 8% gel (left panel) and F(ab9)2
(10 mg) on a 10% gel (right panel). Gels were stained with colloidal
oomassie Brilliant Blue. Lane 1, IgG; lane 2, Fab; lane 3, F(ab9)2; lane
4, IgG. The positions of marker proteins are indicated.(Gibco) in 199 medium buffered with sodium bicarbon-
ate, containing 0.2% (w/v) bovine serum albumin (BSA),0.01% (w/v) DEAE dextran, 100 U/ml penicillin, 100 mg/ml
streptomycin, and 30 U/ml TPCK trypsin (all from Sigma).
After incubation for 3 days at 33°C, monolayers were
fixed with formal-saline and stained with toluidine blue
(BDH; Merck, Lutterworth, UK) for plaque counting.
Neutralization assay
Two methods were used. In the first, reduction in
plaque number was determined. Virus (100 PFU/ml) was
mixed with an equal volume of a range of dilutions of
Mab for 60 min at 37°C, and then inoculated onto MDCK
or BHK monolayers as described above. Neutralization
was calculated as a percentage of the virus control and
subtracted from 100. The second assay was a neutral-
ization ELISA carried out in 96-well plates or 3-cm diam-
eter dishes (Ho¨rling et al., 1992). This was used to mea-
sure infectivity loss relative to attachment and internal-
ization of virus that were assayed in the same format.
The incubated virus–Mab mix (100 ml) was inoculated
onto washed MDCK 96-well monolayers (Gibco) and
incubated for 25 min at 4°C. After rinsing, 100 ml of warm
MEM, 1% HIFCS, 2 mM glutamine, and 20 mg/ml gen-
tamicin were added, and the plate was incubated over-
night at 37°C in the absence of trypsin, so that there was
replication only within the original infected cell. Cells
were then fixed with 2% paraformaldehyde in PBS and
blocked with 3% BSA in TBS (0.02 M Tris–HCl, 0.14 M
NaCl, pH 7.6) for 90 min at 20°C. De novo expressed HA
on the cell surface was assayed as a measure of virus
replication and detected with monoclonal mouse anti-HA
IgA (H37-66-1), an anti-IgA alkaline phosphatase conju-
gate (Sigma), and DNPP. The product was read on an
optical plate reader (Titertek Multiscan Plus; Life Sci-
ences International) at 405 nm, where the virus control
had an OD of approximately 1.1. All virus–antibody mix-
tures used in neutralization and all other assays were
vortexed for 30 s immediately before inoculation onto
cells, to break up any aggregates (Armstrong and Dim-
mock, 1992).
ELISA for virus attachment
Virus was neutralized and monolayers in 96-well
plates inoculated exactly as described above. After non-
attached virus was removed with cold DMEM, attached
virus was fixed and permeabilized with cold methanol
and blocked with 3% BSA in TBS overnight at 4°C. At-
tached virus was detected using an NP-specific Mab
(HB-67, IgG1) in 1% BSA in TBS containing 0.1% Tween
(Sigma). The NP antibody was then detected with rabbit
anti-mouse IgG1 (Dako, Ely, UK), goat anti-rabbit alkaline
phosphatase conjugate (Dako), and DNPP. The product
was read as described above. As a negative control,
cells were treated twice before virus inoculation with
Clostridium perfringens neuraminidase type V (Sigma;
0.025 U for 10 min at 37°C) to remove N-acetylneura-
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433COMPLEX AND SIMPLE NEUTRALIZATIONminic acid (NANA) receptors. Neutralization by ELISA
was determined in the same system at the same time.
ELISA of the internalization of virus by cells
A virus–Mab mix containing 1500 HAU/ml was incu-
bated for 60 min at 37°C, to allow neutralization to occur.
The mix (100 ml) was inoculated onto a washed MDCK
monolayer in a 96-well plate and incubated for 25 min at
4°C. After washing with cold DMEM, monolayers were
incubated with warm DMEM at 37°C for 30 min to allow
the attached virus to be internalized. Noninternalized
virus was removed by treating the monolayer twice with
0.025 U of C. perfringens neuraminidase for 10 min at
37°C. Monolayers were then permeabilized by freeze–
thaw cycle three times and fixed in 220°C methanol in
saline for 30 min. After washing in TBS–Tween, mono-
layers were blocked with 3% BSA in TBS overnight at
4°C. Virus was detected as virion NP antigen as de-
scribed above. To show that virus was being internalized
by receptor-mediated endocytosis, we used conditions
that are known to inhibit this process: either 4°C (Matlin
et al., 1981; Richman et al., 1986) or incubating cells in
hypertonic medium (0.45 M sucrose in medium) for 30
min at 20°C before inoculation of virus. This latter con-
dition prevents the clathrin lattice formation required for
receptor-mediated endocytosis (Daukas and Zigmond,
1985; Heuser and Anderson, 1989). Virus internalization
and neutralization were determined in exactly the same
96-well system. Neutralization was determined by ELISA
in the same system at the same time. Internalization data
relate only to virus that attached to cells, and these were
determined in the same cell culture system as described
above.
Assay for virus–cell fusion using virus labeled with
octadecyl rhodamine B chloride (R18)
Freshly purified virus (1.25 3 107 HAU in 500 ml) was
ixed with 5 ml of R18 (85.5 mM; Molecular Probes
urope BV, Leiden, The Netherlands) for 60 min at 20°C
n the dark. After centrifuging to remove any precipitate,
ree R18 was removed by pelleting virus through 20%
ucrose at 110,000 g for 90 min. Virus was resuspended
n 100 ml of PBS and stored at 270°C. Solubilization of
18-labeled virus in 1% Triton X-100 (BDH) gave a 150-
old increase in fluorescence, indicating that the R18 was
elf-quenched and incorporated into the virus lipid bi-
ayer. For assay of fusion, nonneutralized virus or neu-
ralized R18-labeled virus (200 HAU in 100 ml) was inoc-
lated onto a 3-cm-diameter monolayer of MDCK or BHK
ells for 25 min at 4°C. Unbound virus was removed with
old DMEM, and 200 ml of warm DMEM was added for
30 min at 37°C. Cells were again washed with cold
DMEM and detached from the plastic by incubation with
cold versene for 5 min at 20°C and scraping. These were
pelleted and fixed by resuspending in cold 2% parafor-maldehyde in the dark. Fluorescence was determined
using a Luminescence Spectrophotometer LS-5 (Perkin–
Elmer, Beaconsfield, UK), exciting at 560 nm and emitting
at 590 nm, with an emission slitwidth of 10 nm. To
demonstrate the specificity of the fluorescent signal,
cells inoculated with R18-labeled virus either were kept
at 4°C to inhibit fusion (Matlin et al., 1981; Richman et al.,
1986) or were treated prior to infection with 500 nM
bafilomycin A1 from Streptomyces griseus (Calbiochem:
Novabiochem (UK), Beeston, UK) for 90 min at 37°C.
Bafilomycin inhibits V-ATPase and prevents the acidifica-
tion of endosomal vesicles, required to trigger HA-medi-
ated fusion (Palokangas et al., 1994; Ochiai et al., 1995).
usion data were calculated relative to the percentage of
irus that attached to cells, measured in the same sys-
em. This was done by determining the amount of at-
ached virus relative to the nonneutralized virus control
rom the fluorescent signal obtained after treatment with
riton X-100. The fusion ability of neutralized virus was
alculated as a percentage of that achieved by the non-
eutralized virus control. To keep the assays compara-
le, fusion and neutralization by ELISA were determined
n the same 3-cm-diameter dish system at the same time.
he neutralization assay was carried out exactly as the
ormal 96-well ELISA, except that the volumes were
caled up. The colored product was then transferred to
6-well plates for reading.
ssay of the affinity of Mabs and their Fab fragments
or virions using surface plasmon resonance
The method was based on our earlier data (Schofield
nd Dimmock, 1996). Initially HA-specific monoclonal
37 IgG was covalently bound to a CM5 biosensor chip
f a BIAcore 2000 (Biacore AB) by amine coupling. Any
ab bound nonspecifically was removed with 0.05 M
riethylamine (Sigma). Purified virus (320 HAU in 40 ml)
was suspended in 100 mg/ml CM5 dextran in HEPES-
buffered saline (HBS; Fluka: Sigma), to prevent nonspe-
cific interactions, and was captured on to the chip via the
H37 IgG. The signal from the blank control, lane 1, is
subtracted from the signal in lane 2, so that bulk refrac-
tive index changes are minimized and the sensorgram
shows actual binding events. Approximately 700 refrac-
tive units (RU) of virus was bound and used for kinetic
analysis of Mabs and Fabs. Kinetic measurements for
each Mab and Fab pair were made simultaneously at
25°C on the same chip surface to minimize the effect of
surface differences on kinetics. At least three different
antibody concentrations were used. Antibody in HBS
containing 10 mg/ml CM5 dextran was injected over
lanes 1 and 2 at a flow rate of 20 ml/min and a dissoci-
ation time of 600 s. Afterward the chip surface was
regenerated back to the covalently coupled Mab H37 by
eluting bound virus with 0.05 M triethylamine. Kinetics of
the binding of the Mabs and Fabs was analyzed using
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434 EDWARDS AND DIMMOCKthe BIA evaluation software package (version 2.2). Data
were analyzed by fitting each concentration of antibody
to a Langmuir 1-to-1 binding model. Initially, the off-rate
(kd) was calculated by selecting 300 s of dissociation
data (kept constant to compare Mabs and Fabs) and this
rate was used along with the analyte concentration in
moles to determine the on-rate (ka). The equilibrium
dissociation constant is kd/ka.
ata analysis
Dose–response curves were calculated by nonlinear
egression analysis using Prism Graphpad software. To
etermine whether they were significantly different, we
ompared the complete curves using an unpaired t test,
here a value of P , 0.05 is considered significant.
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